Insider buying last 90 days
No open-market insider purchases were filed for SNPS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every SNPS insider filing, plotted on the chart in Gekko.Open SNPS in Gekko
NASDAQ: SNPS
Synopsys (SNPS) Stock Analysis & Forecast
Nov 4 close
$462.95+0.07 (0.0%)
Gekko Brief
AI summaryNov 4 closeSynopsys announces an agreement with the European Chips Joint Undertaking to make its electronic design automation software available to semiconductor startups and SMEs through the European Chips Design Platform, extending the reach of its EDA tools. Separately, Argus has raised its target price for Synopsys to $571.00, citing the company's position in EDA software and intellectual property products. Commentary elsewhere has pointed to the company's growing reliance on AI-driven design starts as a risk, even as non-AI design activity has stabilized.
Synopsys closes at $462.95, sitting between its 50-day average of $441.29 and 200-day average of $442.75, with returns of -8.4% over one month, 14% over three months, and 3.9% over one year. The GekkoIndex reads 58.1, placing the stock in the Neutral zone. Price stands 11.6% above Gekko Fair Value of $414.99.
The next earnings date falls on 9 December 2026, after close, 34 days away and outside a typical 20-trading-day hold; the prior report on 26 August 2026 saw EPS of $2.30 against a $2.66 estimate, with a 13.7% reaction. Analyst coverage from 19 firms shows 18 buy ratings and 1 hold, with a consensus target of $586.95. Seasonality from this point in the calendar has averaged a 10% return over the next 20 trading days across 5 years, rising in 5 of them. No insider, Congress, or unusual options activity appears in the current window.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Synopsys price vs fair value
Close $462.95200-day averageGekko Fair Value $414.99
Synopsys quick facts
- Market cap
- $88.72B
- P/E ratio
- 82.4
- Forward P/E
- 25.8
- EPS, TTM
- $5.66
- Revenue, TTM
- $9.42B
- Profit margin
- 11.4%
- Dividend yield
- —
- Beta
- 1.18
- Volume
- 1.77M avg 2.17M
- 1-year return
- +3.9%
- Typical daily move
- ±4.1%
- Typical 20-day move
- ±7.2%
- 50-day average
- $441.29
- 200-day average
- $442.75
- Next earnings
- Dec 9 after close
- Shares outstanding
- 191.6M
Synopsys swing-trade checklist
Synopsys scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $462.95 sits between the 50-day ($441.29) and 200-day ($442.75) averages, or the averages disagree.
See the chart - GekkoIndexmixed
58.1, Neutral
Reading 58.1 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
11.6% above
Price is 11.6% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 34 days
Next report Dec 9, 2026, 34 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+10.0% on average
From this point in the calendar, the next 20 trading days averaged +10% over 5 years, rising in 5 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Synopsys stock chart and price history
Synopsys closed at $462.95 on Nov 4, 2026, +3.9% over the past year, inside a 52-week range of $362.55 to $539.48.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −8.4%
- 3 months
- +14.0%
- 6 months
- −8.2%
- 1 year
- +3.9%
The full SNPS chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open SNPS in Gekko
Follow Synopsys through every session
Put SNPS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track SNPS in GekkoFree for 7 days. No credit card required.
About Synopsys
Synopsys makes software used to design, test and build integrated circuits, giving engineers tools to lay out digital chips, verify their behavior through simulation and emulation, and prototype designs before manufacturing. It is known for its chip design and verification platforms, which cover everything from early architecture planning to debugging finished designs, and it also builds tools for programming FPGAs and for modeling optical and photonic systems.
Much of its business rests on licensing pre-built intellectual property blocks, covering common communication standards, analog components, processor cores, memory, and security functions, that chipmakers can drop into their own designs rather than build from scratch. Synopsys rounds this out with services such as security testing, training and managed support to help clients catch flaws during development, plus tools aimed at manufacturing. Its customers span electronics, automotive, medical, energy, financial services and other industrial fields worldwide.
Synopsys was founded in 1986 and is based in Mountain View, California. Its shares trade on the NASDAQ under the ticker SNPS.
- Listed
- NASDAQ
- Sector
- Technology services
- Industry
- Packaged software
- Website
- synopsys.com
Synopsys GekkoIndex: the smart money zone
Synopsys’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 58.1, in the Neutral zone, up 4.3 points over five sessions.
58.1Neutral
Up 4.3 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 46 | +4.0% | +6.1% | ||
| Accumulation | 264 | 0.0% | +2.7% | ||
| Neutral (current zone) | 345 | −0.2% | −2.5% | ||
| Distribution | 41 | −0.5% | +1.7% | ||
| Selling | 1 | Too few readings yet | |||
Average SNPS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the SNPS price, zone by zone.Track SNPS in Gekko
Is Synopsys stock overvalued? Gekko Fair Value
Synopsys trades 11.6% above Gekko Fair Value of $414.99, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Synopsys shares are worth, recalculated every trading day.
$414.99
Gekko Fair Value, Nov 4, 2026
11.6% Overvalued
At the end of Aug 2026 the price was 9.5% above the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open SNPS in Gekko
Synopsys insider and Congress trading
No open-market insider purchases were filed for Synopsys, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in SNPS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for SNPS, plotted on the chart in Gekko.Open SNPS in Gekko
Buybacks
Synopsys has been buying back its own shares.
- Latest authorization
- $2.00B, Feb 25, 2026
- Bought back, quarter ended Jul 31, 2026
- $37.50M
- As a share of market cap
- 0.04%
From company filings.
Hedge funds and billionaires quarter ended Jun 30
5of the funds Gekko tracks hold SNPS.
0added1opened4trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
Synopsys earnings: next date and track record
Synopsys reports on Dec 9, 2026, after the close (34 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Dec 9, 2026
Expected after the close, 34 days away
- EPS estimate
- $4.12
- Revenue estimate
- $2.56B
5 of 8reports beat the EPS estimate
±10.9%average move across the report
2 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Aug 26, 2026 AI summary
- What they said
- Synopsys delivered Q3 FY2026 results exceeding guidance on revenue, non-GAAP operating margin, and EPS, driven by EDA outperformance, record hardware revenue, and strong Ansys integration. The company launched Multiphysics Fusion, its first joint Synopsys-Ansys product, validated by NVIDIA, Cisco, MediaTek, and Samsung Foundry with up to 10x faster design closure. Design IP returned to growth, and agentic AI initiatives showed strong traction with 30+ active customer engagements.
- Guidance
- Synopsys raised full-year revenue, non-GAAP operating margin, and EPS guidance. EDA growth is expected to accelerate to double digits in Q4 and for the full year. Multiphysics Fusion add-on capabilities are expected to contribute to EDA growth beginning in 2027.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 26, 2026 | $2.30 est $2.66 | $2.48B est $2.44B | +13.7% |
| May 27, 2026 | $0.00 est $3.16 | $2.28B est $2.25B | −10.1% |
| Feb 25, 2026 | $3.77 est $3.56 | $2.41B est $2.39B | −3.3% |
| Dec 10, 2025 | $2.90 est $2.78 | $2.25B est $2.25B | +2.4% |
| Sep 9, 2025 | $3.39 est $3.80 | $1.74B est $1.77B | −36.3% |
| May 28, 2025 | $3.67 est $3.39 | $1.60B est $1.60B | −11.1% |
| Feb 26, 2025 | $3.03 est $2.79 | $1.46B est $1.45B | −0.7% |
| Dec 4, 2024 | $3.40 est $3.30 | $1.64B est $1.63B | −9.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Synopsys stock forecast and analyst price targets
Analysts’ average 12-month price target for Synopsys is $586.95, +26.8% from the last close, from 19 firms rating the stock in the last 90 days.
$586.95consensus 12-month target, +26.8% from the last close
Now $462.95Avg $586.95
Low $420High $700
Each firm’s latest rating in the last 90 days: 19 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 20 | Morgan Stanley | $574 | +24.0% |
| Oct 20 | Morgan Stanley | $574 | +24.0% |
| Oct 12 | Needham | $620 | +33.9% |
| Oct 8 | Bank of America Securities | $600 | +29.6% |
| Oct 1 | KeyBanc | $605 | +30.7% |
−2.5%average 20-day move after past Neutral readings
+10.0%average move over the next 20 trading days in the last 5 years
±4.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Synopsys seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, Synopsys averaged +10.0% across the last 5 years, rising in 5 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +5.4% | 3 of 5 |
| Next 10 trading days | +4.5% | 3 of 5 |
| Next 15 trading days | +6.8% | 4 of 5 |
| Next 20 trading days | +10.0% | 5 of 5 |
| Next 30 trading days | +8.0% | 4 of 5 |
For scale, SNPS’s typical 20-trading-day move in either direction is about 7.2%.
Synopsys market cap and key statistics
Synopsys’s market cap is $88.72B, with a P/E ratio of 82.4 and revenue of $9.42B over the last twelve months.
Valuation
- Market cap
- $88.72B
- P/E ratio
- 82.4
- Forward P/E
- 25.8
- EPS, TTM
- $5.66
- Gekko Fair Value
- $414.99
Trading
- Volume
- 1.77M
- Avg volume, 20 days
- 2.17M
- 52-week high
- $539.48
- 52-week low
- $362.55
- Shares outstanding
- 191.6M
Financials
- Revenue, TTM
- $9.42B
- Profit margin
- 11.4%
- Return on equity
- 3.7%
- Quarterly earnings growth, YoY
- +89.3%
Risk and income
- Beta
- 1.18
- Typical daily move
- ±4.1%
- Typical 20-day move
- ±7.2%
Synopsys stock news this week
Coverage of Synopsys this week reads positive: 9 positive, 8 neutral and 2 negative headlines.
- Synopsys to Offer EDA Software Through European Chips Design PlatformHPCwire, Nov 4
- Synopsys Expands Access to Advanced Chip Design Capabilities Through European Chips Design PlatformSynopsys, Nov 4
- Synopsys, Inc. (SNPS) Stock forecastsYahoo Finance UK, Nov 4
- What Is The One Risk Every Synopsys Investor Should Know?Trefis, Nov 3
- The Big 3: LUV, SNPS, BBYSchwab Network, Nov 3
- International Business Machines vs. Synopsys: Which Technology Stock Is a Better Buy for 2027?The Globe and Mail, Nov 2
Synopsys peers
Synopsys’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSFTMicrosoft | Neutral | 17.8% above |
| PLTRPalantir Technologies | Accumulation | 4.7% below |
| ORCLOracle | Accumulation | 29.7% below |
| PANWPalo Alto Networks | Accumulation | 7.4% above |
| CRWDCrowdStrike | Neutral | 8.1% above |
| CRMSalesforce | Accumulation | 9.3% below |
A peer links to its own page where one exists.
Synopsys stock FAQ
What is Synopsys’s market cap?
Synopsys’s market cap is $88.72B at the Nov 4, 2026 close of $462.95, with 191.6M shares outstanding. The shares trade on a P/E ratio of 82.4.
What is the Synopsys stock forecast?
The consensus analyst 12-month price target for Synopsys is $586.95, +26.8% from the last close. Of the 19 firms that rated the stock in the last 90 days, 18 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Synopsys stock overvalued or undervalued?
On Gekko’s estimate Synopsys is overvalued: the Nov 4, 2026 close of $462.95 is 11.6% above Gekko Fair Value of $414.99. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Synopsys report earnings next?
Synopsys is expected to report on Dec 9, 2026, after the market closes (34 days away). Analysts expect earnings of $4.12 per share on revenue of $2.56B. Synopsys beat the earnings estimate in 5 of its last 8 reports, moving 10.9% on average across the report.
What is Synopsys’s 52-week high and low?
Synopsys’s 52-week high is $539.48 and its 52-week low is $362.55; it closed at $462.95 on Nov 4, 2026, +3.9% over the past year. Over the last five years the shares peaked at $651.73 on Jul 30, 2025.
Is Synopsys stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (earnings risk and seasonality), 2 as mixed (trend and gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Synopsys the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,460 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.